Canadian Solar (CSIQ)
(Delayed Data from NSDQ)
$16.44 USD
+1.29 (8.51%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $16.45 +0.01 (0.06%) 6:14 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Brokerage Reports
0 items in cart
Canadian Solar Inc. [CSIQ]
Reports for Purchase
Showing records 1181 - 1200 ( 1222 total )
Company: Canadian Solar Inc.
Industry: Solar
Company: Canadian Solar Inc.
Industry: Solar
Renewable Technologies -The Year Solar Re-Took the Skies - Introducing 2012 Estimates
Provider: AURIGA USA
Analyst: BACHMAN M
Company: Canadian Solar Inc.
Industry: Solar
Watts Up: California Market December Solar Survey.
Provider: WEDBUSH SECURITIES INC.
Analyst: HERSEY C
Company: Canadian Solar Inc.
Industry: Solar
Company: Canadian Solar Inc.
Industry: Solar
Company: Canadian Solar Inc.
Industry: Solar
Solar Technology - California Market November Solar Survey.
Provider: WEDBUSH SECURITIES INC.
Analyst: HERSEY C
Company: Canadian Solar Inc.
Industry: Solar
Company: Canadian Solar Inc.
Industry: Solar
Company: Canadian Solar Inc.
Industry: Solar
Company: Canadian Solar Inc.
Industry: Solar
Company: Canadian Solar Inc.
Industry: Solar
Watts Up: Notes from Solar Power International - Day 3This report contains brief updates on the following: CSIQ, TSL, SOLF, YGE. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: WEDBUSH SECURITIES INC.
Analyst: HERSEY C
Company: Canadian Solar Inc.
Industry: Solar
Solar Technology -Watts Up: Notes from Solar Power International Day 2
Provider: WEDBUSH SECURITIES INC.
Analyst: HERSEY C
Company: Canadian Solar Inc.
Industry: Solar
Solar Technology -Watts Up: Notes from Solar Power International
Provider: WEDBUSH SECURITIES INC.
Analyst: HERSEY C
Company: Canadian Solar Inc.
Industry: Solar
Company: Canadian Solar Inc.
Industry: Solar
Company: Canadian Solar Inc.
Industry: Solar
Company: Canadian Solar Inc.
Industry: Solar
Company: Canadian Solar Inc.
Industry: Solar
Q2 Revenue Beat Expectations; Expect Margin Improvement with Higher Cell Production; Adjusting Estimates and Raising Price Target to $12; Maintain NEUTRAL Rating.
Provider: WEDBUSH SECURITIES INC.
Analyst: HERSEY C